Literature DB >> 20159947

Increased insertion of glutamate receptor 2-lacking alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors at hippocampal synapses upon repeated morphine administration.

Sophie K Billa1, Jie Liu, Nicole L Bjorklund, Namita Sinha, Yu Fu, Patricia Shinnick-Gallagher, Jose A Morón.   

Abstract

Evidence suggests that the long-term adaptations in the hippocampus after repeated drug treatment may parallel its role during memory formation. The neuroplasticity that subserves learning and memory is also believed to underlie addictive processes. We have reported previously that repeated morphine administration alters local distribution of endocytic proteins at hippocampal synapses, which could in turn affect expression of glutamate receptors. Glutamatergic systems, including alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs), are believed to be involved in opiate-induced neuronal and behavioral plasticity, although the mechanisms underlying these effects are only beginning to be understood. The present study further examines the effects of repeated morphine administration on the expression and composition of AMPARs and the functional ramifications. Twelve hours after the last morphine injection, we observed an increased expression of AMPARs lacking glutamate receptor (GluR) 2 in hippocampal synaptic fractions. Immunoblotting studies show that 12 h after morphine treatment, GluR1 subunits are increased at the postsynaptic density (PSD) and at extrasynaptic sites, whereas GluR3 subunits are only increased at the PSD, and they show how this alters receptor subunit composition. In addition, we provide electrophysiological evidence that AMPARs are switched to Ca(2+)-permeable (GluR2-lacking) at the synapse 12 h after repeated morphine treatment, affecting the magnitude of long-term depression at hippocampal neurons. We propose that morphine-induced changes in glutamatergic synaptic transmission in the hippocampus may play an important role in the neuroadaptations induced by repeated morphine administration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20159947      PMCID: PMC2872965          DOI: 10.1124/mol.109.060301

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  32 in total

Review 1.  Role of AMPA receptors in synaptic plasticity.

Authors:  Rolf Sprengel
Journal:  Cell Tissue Res       Date:  2006-08-01       Impact factor: 5.249

Review 2.  Regulatory mechanisms of AMPA receptors in synaptic plasticity.

Authors:  Victor A Derkach; Michael C Oh; Eric S Guire; Thomas R Soderling
Journal:  Nat Rev Neurosci       Date:  2007-02       Impact factor: 34.870

Review 3.  Probing the role of AMPAR endocytosis and long-term depression in behavioural sensitization: relevance to treatment of brain disorders, including drug addiction.

Authors:  Y T Wang
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

4.  Age-dependent requirement of AKAP150-anchored PKA and GluR2-lacking AMPA receptors in LTP.

Authors:  Yuan Lu; Margaret Allen; Amy R Halt; Michael Weisenhaus; Robert F Dallapiazza; Duane D Hall; Yuriy M Usachev; G Stanley McKnight; Johannes W Hell
Journal:  EMBO J       Date:  2007-11-01       Impact factor: 11.598

Review 5.  Synaptic plasticity and addiction.

Authors:  Julie A Kauer; Robert C Malenka
Journal:  Nat Rev Neurosci       Date:  2007-11       Impact factor: 34.870

6.  Morphine administration alters the profile of hippocampal postsynaptic density-associated proteins: a proteomics study focusing on endocytic proteins.

Authors:  José A Morón; Noura S Abul-Husn; Raphael Rozenfeld; Georgia Dolios; Rong Wang; Lakshmi A Devi
Journal:  Mol Cell Proteomics       Date:  2006-10-06       Impact factor: 5.911

7.  Stabilization of Ca2+-permeable AMPA receptors at perisynaptic sites by GluR1-S845 phosphorylation.

Authors:  Kaiwen He; Lihua Song; Laurel W Cummings; Jonathan Goldman; Richard L Huganir; Hey-Kyoung Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-05       Impact factor: 11.205

8.  Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving.

Authors:  Kelly L Conrad; Kuei Y Tseng; Jamie L Uejima; Jeremy M Reimers; Li-Jun Heng; Yavin Shaham; Michela Marinelli; Marina E Wolf
Journal:  Nature       Date:  2008-05-25       Impact factor: 49.962

9.  Long-term potentiation in the hippocampal CA1 region does not require insertion and activation of GluR2-lacking AMPA receptors.

Authors:  Erin E Gray; Ann E Fink; Joshua Sariñana; Bryce Vissel; Thomas J O'Dell
Journal:  J Neurophysiol       Date:  2007-07-25       Impact factor: 2.714

10.  Enhanced CREB and DARPP-32 phosphorylation in the nucleus accumbens and CREB, ERK, and GluR1 phosphorylation in the dorsal hippocampus is associated with cocaine-conditioned place preference behavior.

Authors:  Thomas F Tropea; Barry E Kosofsky; Anjali M Rajadhyaksha
Journal:  J Neurochem       Date:  2008-06-28       Impact factor: 5.372

View more
  26 in total

1.  Hippocampal GluA1-containing AMPA receptors mediate context-dependent sensitization to morphine.

Authors:  Yan Xia; George S Portugal; Amanda K Fakira; Zara Melyan; Rachael Neve; H Thomas Lee; Scott J Russo; Jie Liu; Jose A Morón
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

2.  Alterations in AMPA receptor subunits and TARPs in the rat nucleus accumbens related to the formation of Ca²⁺-permeable AMPA receptors during the incubation of cocaine craving.

Authors:  Carrie R Ferrario; Jessica A Loweth; Mike Milovanovic; Kerstin A Ford; Gregorio L Galiñanes; Li-Jun Heng; Kuei Y Tseng; Marina E Wolf
Journal:  Neuropharmacology       Date:  2011-01-27       Impact factor: 5.250

3.  Selective, quantitative measurement of releasable synaptic zinc in human autopsy hippocampal brain tissue from Alzheimer's disease patients.

Authors:  Nicole L Bjorklund; V-M Sadagoparamanujam; Giulio Taglialatela
Journal:  J Neurosci Methods       Date:  2011-09-16       Impact factor: 2.390

4.  Differential modulation of drug-induced structural and functional plasticity of dendritic spines.

Authors:  Eric C Miller; Lei Zhang; Benjamin W Dummer; Desmond R Cariveau; Horace Loh; Ping-Yee Law; Dezhi Liao
Journal:  Mol Pharmacol       Date:  2012-05-17       Impact factor: 4.436

5.  Involvement of AMPA/Kainate Glutamate Receptor in the Extinction and Reinstatement of Morphine-Induced Conditioned Place Preference: A Behavioral and Molecular Study.

Authors:  Ali Siahposht-Khachaki; Zahra Fatahi; Asal Yans; Fariba Khodagholi; Abbas Haghparast
Journal:  Cell Mol Neurobiol       Date:  2016-04-06       Impact factor: 5.046

6.  Hippocampal long-term potentiation is disrupted during expression and extinction but is restored after reinstatement of morphine place preference.

Authors:  George S Portugal; Ream Al-Hasani; Amanda K Fakira; Jose L Gonzalez-Romero; Zare Melyan; Jordan G McCall; Michael R Bruchas; Jose A Morón
Journal:  J Neurosci       Date:  2014-01-08       Impact factor: 6.167

7.  GluR2-3Y Inhibits the Acquisition and Reinstatement of Morphine-Induced Conditioned Place Preference in Rats.

Authors:  Xiao-Jing Lin; Jian-Jun Zhang; Long-Chuan Yu
Journal:  Neurosci Bull       Date:  2016-02-29       Impact factor: 5.203

8.  Dynamic increases in AMPA receptor phosphorylation in the rat hippocampus in response to amphetamine.

Authors:  Li-Min Mao; Bing Xue; Dao-Zhong Jin; John Q Wang
Journal:  J Neurochem       Date:  2015-03-02       Impact factor: 5.372

Review 9.  The Opioid-Addicted Tetrapartite Synapse.

Authors:  Anna Kruyer; Vivian C Chioma; Peter W Kalivas
Journal:  Biol Psychiatry       Date:  2019-06-13       Impact factor: 13.382

10.  A role for calcium-permeable AMPA receptors in synaptic plasticity and learning.

Authors:  Brian J Wiltgen; Gordon A Royle; Erin E Gray; Andrea Abdipranoto; Nopporn Thangthaeng; Nate Jacobs; Faysal Saab; Susumu Tonegawa; Stephen F Heinemann; Thomas J O'Dell; Michael S Fanselow; Bryce Vissel
Journal:  PLoS One       Date:  2010-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.